Financials
- Fiscal year
- 2025
- Total assets
- €3.6m
- Profit
- €412,067
- Solvency
- 73.6%
BELGOPHARMA
ActiveSummary
BELGOPHARMA has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.7m and a net result of €412,067. Equity is growing by ~129.9% per year across the filed fiscal years. Its solvency ranks better than 80% of 5451 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€3.6mtotal assets 2025
- Equity
- €2.7m
- Profit
- €412,067
Structure
Accounts 9 d early0 of 2 deeds read
Why 98- Founded in 2021+ Size: total assets €3.6m+ Figures for FY 2025 (filed 22-07-2026)+ Liquidity: current ratio 3.14, cash €1.3mShow the evidence
Checked score
Score 2025
98
/ 100
Excellent
Probability in this band: under 0.55%
Better than 86% of its sector peers (NACE 46, small)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency
99+6
equity 73.6% of total assets
Liquidity
86=
short-term debt 26.3% · cash 36.6%
Profitability
83-17
return on assets 11.3%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 10 months
01-2026: < 0.1%lowest value
02-2026: < 0.1%● 0.0% vs 01-2026lowest value
03-2026: < 0.1%▲ +9.1% vs 02-2026
04-2026: < 0.1%▲ +4.2% vs 03-2026
05-2026: < 0.1%● 0.0% vs 04-2026
06-2026: 0.1%▲ +36.0% vs 05-2026
07-2026: 0.1%▲ +27.9% vs 06-2026highest value
08-2026: < 0.1%▼ -47.1% vs 07-2026
09-2026: < 0.1%● 0.0% vs 08-2026
10-2026: < 0.1%▼ -2.2% vs 09-2026
- Size: total assets €3.6m lowers the probability for this profile
- Figures for FY 2025 (filed 22-07-2026) lowers the probability
- Liquidity: current ratio 3.14, cash €1.3m lowers the probability
- Founded in 2021 raises the probability for this profile
Credit up to €260,000 at 30 days acceptable
Liquidity ample (current ratio 3.14 against 3.13 in 2024; short-term debt: 26.3% and cash: 36.6% of total assets), and 26.4% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, small). Better than this share of them on solvency 83%, liquidity 95%, profitability 86%, growth against the median 80%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
9 d early
2024
29 d late
2023
25 d late
2022
30 d late
2021
30 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 21 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 29 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · full…
- Annual accounts filedfiscal year 2024 · full…
- Highest result since 2021net €1.2m ▲111%
Key points
By topic
Timeline
- Events
- 10
- Since
- 2022
- Next accounts
- by 31-07-2027
- 22-07-2026Annual accounts filed
- 29-08-2025Annual accounts filed
- 31-12-2024Highest result since 2021
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 04-02-2021
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.